Skip to main content

Table 5 PCR uncorrected adequate clinical and parasitological response (ACPR) at day 42 (intention to treat population)

From: Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study

  Arterolane maleate and piperaquine phosphate 95 % CI
Overall Age (6 months to ≤12years) (n = 141)
 Success, n (%) 124 (87.9) (81.40, 92.82)
Age group 1 (6 months to <2years) (n = 22)
 Success, n (%) 19 (86.4) (65.09, 97.09)
Age group 2 (2 to <6years) (n = 49)
 Success, n (%) 42 (85.7) (72.76, 94.06)
Age group 3 (6 to ≤12 years) (n = 70)
 Success, n (%) 63 (90.0) (80.48, 95.88)